Impact Factor
4.20
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
4.59
5,906 total citations
h5-index
63
h5 depth signal
Cited share
82.2%
1,108 of 1,348
Total citations
5,906
Citation footprint
Metric signal
4.31
External metric anchor
Self-citation
2.1%
123 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
Canada
1,739
United States
875
Italy
477
China
446
Japan
207
Citing Fields of Research
Oncology
1,795
Breast Cancer
699
Palliative Care
545
Lung Cancer
515
Liver & Colon Cancer
433
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
5,762
Articles tracked across the journal lifetime
Indexed publication set
1,348
1,108 cited publications
Last 12 months
755
62.9 publications/month
Open access share
100.0%
755 OA publications in the last year
Leading citing country
Canada
1,739 citing publications
Leading citing field
Oncology
1,795 citing publications
Latest tracked publication
20 October 2026
10 recent records available
Coverage & Indexing History
v25n1, 2018-
v13n1, Feb. 2006-
Active Coverage
Research Focus & Classification
Indexed Subjects
Oncology
Breast Cancer
Lung Cancer
Palliative Care
Immunology
Liver & Colon Cancer
Broad Categories
Neoplasms
Palliative Care
Lung Cancer
Breast Cancer
Liver & Colon Cancer
Prostate Cancer
Immunology
Digestive Disorders
MeSH Descriptors
Neoplasms
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.3390/curroncol33100637
Open DOI
Integrated Radiobiotherapy: A State-Based Framework for Response-Adaptive Combination Oncology
Background: Cancer care increasingly requires coordinated use of systemic therapy, targeted radionuclide therapy (TRT), and external-beam radiotherapy (EBRT), yet clinical workflows often remain organized around static staging and sequen...
02
DOI 10.3390/curroncol33100636
Open DOI
Cancer-Specific Survival in Octogenarian Breast Cancer Patients: A Competing Risk Analysis of Prognostic Factors
Background: This study evaluated long-term survival outcomes in breast cancer patients aged ≥80 years, focusing on how prognostic factors change when competing mortality risks are considered. Methods: We retrospectively analyzed 106 octo...
03
DOI 10.3390/curroncol33100635
Open DOI
Cancer Cachexia and the Heart: A Review with Focus on China
Cancer cachexia is a systemic, multifactorial syndrome characterized by progressive depletion of skeletal muscle, disruption of metabolic homeostasis, and reduced survival. In experimental models, cachexia-associated mediators, including...
04
DOI 10.3390/curroncol33100634
Open DOI
CBCT-Guided Online Adaptive Ultrahypofractionated Whole-Breast Radiotherapy for Early-Stage Breast Cancer: Dosimetric Outcomes and Acute Toxicity
Ultrahypofractionated whole-breast radiotherapy reduces treatment burden but increases the importance of accurate dose delivery at each fraction. This retrospective single-center study evaluated cone-beam computed tomography-guided onlin...
05
DOI 10.3390/curroncol33100633
Open DOI
Challenges of Conducting a Feasibility Pilot Randomized Controlled Trial During COVID-19 Restrictions: Rivaroxaban Versus Acetyl Salicylic Acid in Patients with Multiple Myeloma on Lenalidomide-Based Therapy (RithMM)
Venous thromboembolism is a serious medical complication with an increased risk in patients with multiple myeloma undergoing combination treatment regimens. Acetylsalicylic acid is routinely used as a method of thromboprophylaxis in mult...
06
We thank Karabuga and Kaya for their Comment on our nationwide C-CAT registry analysis of facility-level medical oncology specialist availability and first-line time to treatment failure (TTF) in lung cancer. We agree that the heterogene...
07
Time to treatment failure (TTF) is a pragmatic endpoint that captures treatment discontinuation for multiple reasons. In a recent nationwide C-CAT registry analysis, Kajiura et al. examined whether facility-level medical oncology special...
08
DOI 10.3390/curroncol33100630
Open DOI
Frequency of Bloodwork in Patients on Immune Checkpoint Inhibitors
Purpose: Immune checkpoint inhibitors (ICIs) are widely used to treat solid tumours. Prolonged use leads to increased bloodwork to monitor for adverse events (AEs). We explored the safety of decreasing bloodwork frequency while administe...
09
DOI 10.3390/curroncol33100629
Open DOI
Canadian National Pancreas Conference 2025: Recent Advances in Patient-Centred Management of Pancreatic Cancer
Pancreatic cancer (PC) is among the most lethal malignancies with slower progress in overall survival and treatment options compared to other cancers. The 2025 Canadian National Pancreas Conference (NPC)—the third biennial event of its k...
10
DOI 10.3390/curroncol33100628
Open DOI
Electroacupuncture Combined with Cognitive Behavioral Therapy for Insomnia Alleviates Insomnia–Anxiety Comorbidity in Gynecological Cancer Patients Undergoing Chemotherapy: A Randomized Controlled Trial
Insomnia and anxiety affect many gynecological cancer patients on chemotherapy, and non-pharmacological options are limited. This randomized trial examined whether adding electroacupuncture (EA) to cognitive behavioral therapy for insomn...
Bibliographical & Catalog Notes
Title from cover.
Print issues ceased with v. 27 (2020).
Also available online.